(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SELLAS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SELLAS

ST13

US500000086863987

Class

5, 42

Filing

86863987

Registration

5991389

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

61

Latest update

05/09/2026

Trademark type

Word

Nice classes

5, 42

Filing date

01/03/2016

Registration date

02/18/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/08/2026

Last transaction

05/09/2026

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

12/09/2019

First use in commerce

12/09/2019

Drawing code

4

Owner type

16

Owner location

New York, NY, US

Examiner

IM, JEAN H

Current location

Historical data usage

Holders and representatives

Holders

SLSG LIMITED LLC
SLSG LIMITED LLC
SELLAS LIFE SCIENCES GROUP LTD.
Sellas Life Sciences Group AG

Representatives

Karen K. Won MINTZ, LEVIN, COHN, FERRIS, GLOVSKY AND POPEO, P.C

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical and biopharmaceutical preparations for the treatment of cancer and central nervous system (CNS) disorders

Class 42

Scientific research and development for medicalpharmaceuticalbiopharmaceutical purposes; consulting in the field of medicalpharmaceuticalbiopharmaceutical research and product development; conducting of clinical trialsfor others and development of pharmaceutical productsbiopharmaceutical productsother therapeutic products; development of cancer vaccinestreatment products for cancer and central nervous system (CNS) disorders

Publications

History of USPTO decisions and trademark events.

61 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

05/08/2026

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

05/08/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/08/2026

E815

TEAS SECTION 8 & 15 RECEIVED

02/17/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/31/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/31/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/31/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

12/31/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

12/31/2025

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

02/18/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

02/18/2020

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/15/2020

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/14/2020

SUPC

STATEMENT OF USE PROCESSING COMPLETE

12/28/2019

IUAF

USE AMENDMENT FILED

12/18/2019

EISU

TEAS STATEMENT OF USE RECEIVED

12/18/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/12/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/12/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/30/2019

EX5G

SOU EXTENSION 5 GRANTED

07/29/2019

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

07/29/2019

EXT5

SOU EXTENSION 5 FILED

07/24/2019

EEXT

SOU TEAS EXTENSION RECEIVED

07/24/2019

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

07/10/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/30/2019

EX4G

SOU EXTENSION 4 GRANTED

01/28/2019

EXT4

SOU EXTENSION 4 FILED

01/28/2019

EEXT

SOU TEAS EXTENSION RECEIVED

01/28/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/31/2018

EX3G

SOU EXTENSION 3 GRANTED

07/27/2018

EXT3

SOU EXTENSION 3 FILED

07/27/2018

EEXT

SOU TEAS EXTENSION RECEIVED

07/27/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/27/2018

EX2G

SOU EXTENSION 2 GRANTED

01/25/2018

EXT2

SOU EXTENSION 2 FILED

01/25/2018

EEXT

SOU TEAS EXTENSION RECEIVED

01/25/2018

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

07/19/2017

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/15/2017

EX1G

SOU EXTENSION 1 GRANTED

07/13/2017

EXT1

SOU EXTENSION 1 FILED

07/13/2017

EEXT

SOU TEAS EXTENSION RECEIVED

07/13/2017

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

01/31/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/06/2016

PUBO

PUBLISHED FOR OPPOSITION

12/06/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/16/2016

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

11/03/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/26/2016

XAEC

EXAMINER'S AMENDMENT ENTERED

10/26/2016

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

10/26/2016

GNEA

EXAMINERS AMENDMENT E-MAILED

10/26/2016

CNEA

EXAMINERS AMENDMENT -WRITTEN

10/26/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/06/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/06/2016

ALIE

ASSIGNED TO LIE

10/02/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/23/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/25/2016

GNRT

NON-FINAL ACTION E-MAILED

04/25/2016

CNRT

NON-FINAL ACTION WRITTEN

04/25/2016

DOCK

ASSIGNED TO EXAMINER

04/19/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/12/2016

NWAP

NEW APPLICATION ENTERED

01/06/2016

Continuous trademark protection

Get notified about every new filing that threatens SELLAS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.